"The Fralin Biomedical Research Institute at VTC makes transformative scientific advances to improve the human experience. As one of the nation’s fastest-growing research enterprises, the Virginia Tech institute is a destination for world-class researchers. The institute’s scientists focus on diseases that are the leading causes of death and suffering in the United States, including brain disease, heart disease, and cancer. In just 10 years, the research institute has experienced unprecedented growth: doubling its enterprise and lab facilities in Roanoke, while also securing laboratory space on the Children’s National Research & Innovation Campus."

During the past decade, Fralin Biomedical Research Institute conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 3 clinical trials were completed, i.e. on average, 11.1% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 3 clinical trials were completed. i.e. 15.8% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fralin Biomedical Research Institute" #1 collaborator was "Carilion Clinic" with 4 trials as a collaborator, "National Cancer Institute (NCI)" with 4 trials as a collaborator, "Ohio State University" with 3 trials as a collaborator, "University of Minnesota" with 3 trials as a collaborator and "Medical University of South Carolina" with 2 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Fralin Biomedical Research Institute" are "Cigarette Smoking" (4 trials), "Hemiparesis" (3 trials), "Alcohol Use Disorder" (2 trials), "Cerebral Palsy" (2 trials) and "Development of LIFU for Clinical Purposes" (2 trials). Many other conditions were trialed in "Fralin Biomedical Research Institute" in a lesser frequency.

Most popular intervention types in "Fralin Biomedical Research Institute" are "Behavioral" (17 trials), "Other" (6 trials), "Device" (3 trials) and "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Episodic Future Thinking" (4 trials), "Episodic future thinking" (2 trials), "12 mg/mL nicotine strength e-liquid" (1 trials), "24 mg/mL nicotine strength e-liquid" (1 trials) and "3 mg/mL nicotine strength e-liquid" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fralin Biomedical Research Institute" are 27 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Fralin Biomedical Research Institute". 1 are not yet recruiting, 9 are recruiting, undefined are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 15 completed trials in Fralin Biomedical Research Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Fralin Biomedical Research Institute, 2 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 23 trials that are defined as “Not Applicable".